AIM

AIM ImmunoTech

13 hedge funds and large institutions have $420K invested in AIM ImmunoTech in 2017 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
13
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change

Top Sellers

1 -$472K
2 -$462K
3 -$5.67K
4
Bank of New York Mellon
Bank of New York Mellon
New York
-$5K
5
Morgan Stanley
Morgan Stanley
New York
-$1K
Name Holding Trade Value Shares
Change
Change in
Stake
1
$156K
2
$149K
3
$24K
4
$17K
5
$16K
6
$13K
7
$11K
8
$7K
9
$7K
10
$6K
11
$5K
12
$5K
13
$3K
14
$1K
15
16
17